Multimodality Intervention for Function and Metabolism in SCI
(i) Spinal cord injuries
(i) Drug: SARM (ii) Behavioral: hybrid exercise
ā
Active, not recruiting
Study to Evaluate the Safety and Efficacy of 13 weeks of the Selective Androgen Receptor Modulator (SARM) GSK2881078 in Chronic Obstructive Pulmonary Disease (COPD)
(i) Cachexia
(i) Drug: GSK2881078 (ii) Placebo
USA
Active, not recruiting
Pembrolizumab and Enobosarm in Treating Patients With Androgen Receptor Positive Metastatic Triple Negative Breast Cancer
(i) Androgen receptor positive (ii) Estrogen receptor negative (iii) HER2/neu negative (iv) And 3 more
(i) Drug: enobosarm (ii) Pembrolizumab
USA
Recruiting
A Selective Androgen Receptor Modulator for Symptom Management in Prostate Cancer